NCT02306538View on ClinicalTrials.gov

Evaluation of Myocardial Changes During BReast Adenocarcinoma Therapy to Detect Cardiotoxicity Earlier With MRI

Active, not recruitingOBSERVATIONAL
Enrollment

180

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

August 31, 2024

Study Completion Date

January 31, 2027

Conditions
Breast Neoplasms
Trial Locations (1)

M5G 2N2

Toronto General Hospital, Toronto

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

University of Toronto

OTHER

lead

University Health Network, Toronto

OTHER

NCT02306538 - Evaluation of Myocardial Changes During BReast Adenocarcinoma Therapy to Detect Cardiotoxicity Earlier With MRI | Biotech Hunter | Biotech Hunter